v3.26.1
Samsung Collaboration - Narrative (Details) - USD ($)
$ in Millions
6 Months Ended
May 26, 2026
Jun. 30, 2026
Dec. 31, 2025
Disaggregation of Revenue [Line Items]      
Other noncurrent liabilities   $ 1,026.0 $ 1,008.0
Brazil      
Disaggregation of Revenue [Line Items]      
Gross profit sharing arrangement percentage   35.00%  
Samsung Bioepis      
Disaggregation of Revenue [Line Items]      
Collaboration agreement period   10 years  
Samsung Bioepis | Renflexis and Brenzys      
Disaggregation of Revenue [Line Items]      
Fixed payment $ 30.0    
Samsung Bioepis | Collaborative Arrangement, Transaction with Party to Collaborative Arrangement | Renflexis and Brenzys      
Disaggregation of Revenue [Line Items]      
Collaboration agreement period 7 years    
Collaborative arrangement, amended future payment term (in years) 9 years    
Intangible asset $ 20.8    
Other noncurrent liabilities $ 20.8    
Amortize the asset useful life (in years) 9 years    
Samsung Bioepis | Brazil      
Disaggregation of Revenue [Line Items]      
Gross profit sharing arrangement percentage   65.00%